MAGGIE LEWIS: Open Payments
NPI 1427438001 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,365 in 152 payments from 31 companies in 2025. Trend: 2023 $2,044 · 2024 $2,251 · 2025 $2,365
Food & beverage: $2,365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $505 |
| ABBVIE INC. | 15 | $219 |
| Lilly USA, LLC | 16 | $200 |
| Phathom Pharmaceuticals, Inc. | 12 | $193 |
| Corcept Therapeutics | 10 | $164 |
| Amgen Inc. | 17 | $145 |
| Xeris Pharmaceuticals, Inc. | 6 | $112 |
| PFIZER INC. | 6 | $106 |
| Astellas Pharma US Inc | 4 | $98 |
| Tandem Diabetes Care, Inc. | 8 | $95 |
Products named: Wegovy, Ozempic, VOQUEZNA, Korlym, VRAYLAR, Veozah, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across IN — which companies pay providers there.
